JD5037

• CAT Number: I007410
• CAS Number: 1392116-14-1
• Molecular Formula: C27H27Cl2N5O3S
• Molecular Weight: 572.51
• Purity: ≥95%
• Synonyms: JD5037; JD-5037; JD 5037.;(S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide
• Target: Cannabinoid Receptor
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: (2S)-2-[[[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-[(4-chlorophenyl)sulfonylamino]methylidene]amino]-3-methylbutanamide
• InChI: InChI=1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1
• InChIKey: GTCSIQFTNPTSLO-RPWUZVMVSA-N
• SMILES: CC(C)C(C(=O)N)N=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4

JD5037（Cat No.:I007410） is a potent, high-purity compound designed for advanced pharmaceutical research, particularly in the study of metabolic disorders and obesity. As a selective cannabinoid receptor type 1 (CB1) inverse agonist, JD5037 is crucial for investigations into appetite regulation, energy balance, and glucose metabolism. It facilitates precise studies in drug development, pharmacodynamics, and pharmacokinetics. With its well-defined chemical properties, JD5037 ensures reliable and reproducible analytical results, enhancing the robustness of experimental data. Ideal for preclinical and clinical research, it integrates seamlessly into existing protocols, offering a dependable solution for high-precision scientific investigations.